MedTrace Logo

New Dermal Filler for Lip Augmentation

NCT03320824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 273

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation

Conditions

  • Lip Augmentation

Interventions

DEVICE

New Dermal Filler

hyaluronic acid

DEVICE

Device: FDA Approved Dermal Filler

hyaluronic acid

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-13
Primary Completion
2018-06-28
Completion
2019-04-23
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320824 on ClinicalTrials.gov